Literature DB >> 3498768

Interleukin 5 and interleukin 4 produced by Peyer's patch T cells selectively enhance immunoglobulin A expression.

P D Murray1, D T McKenzie, S L Swain, M F Kagnoff.   

Abstract

Considerable evidence suggests that the high frequency of B cells committed to the IgA isotype in Peyer's patches is regulated by T lymphocytes. To understand more accurately the mechanism of this immunoregulation, an autoreactive T cell line from Peyer's patches was generated by culturing L3T4+ Peyer's patches T cells with syngeneic B cell blasts. The resulting T cell line, designated PT-1, and a clone derived from this line, PT-1.14, stimulated immunoglobulin secretion in spleen B cells with a preferential enhancement of IgA and IgG1 isotypes. Supernatant derived from concanavalin A-stimulated PT-1 or PT-1.14 cells could also enhance IgA secretion if spleen B cells were preactivated with lipopolysaccharide. Peyer's patches T cell supernatant did not contain IgA-specific binding factors. PT-1 supernatant scored positive in lymphokine assays for interleukin (IL)-2, IL-4 (B cell stimulatory factor 1), IL-5 (B cell growth factor II), and interferon-gamma, whereas PT-1.14 supernatant was positive for IL-4 and IL-5 and negative for IL-2 and interferon-gamma. Only IL-5 enhanced IgA secretion in lipopolysaccharide-activated B cells and this response was increased two- to three-fold by IL-4. These results suggest that the type 2 T helper subset which produces both IL-5 and IL-4 plays a primary role in regulating IgA expression.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3498768

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  57 in total

1.  Activation of cholera toxin-specific T cells in vitro.

Authors:  C O Elson; S Solomon
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

2.  CD8-deficient mice exhibit augmented mucosal immune responses and intact adjuvant effects to cholera toxin.

Authors:  E Hörnquist; D Grdic; T Mak; N Lycke
Journal:  Immunology       Date:  1996-02       Impact factor: 7.397

Review 3.  Regulation of IgE synthesis in humans.

Authors:  D Vercelli; R S Geha
Journal:  J Clin Immunol       Date:  1989-03       Impact factor: 8.317

4.  Cognate T-cell help in the induction of IgA responses in vivo.

Authors:  M L Dunkley; A J Husband; B J Underdown
Journal:  Immunology       Date:  1990-09       Impact factor: 7.397

5.  B cell-intrinsic and -extrinsic regulation of antibody responses by PARP14, an intracellular (ADP-ribosyl)transferase.

Authors:  Sung Hoon Cho; Ariel Raybuck; Mei Wei; John Erickson; Ki Taek Nam; Reagan G Cox; Alyssa Trochtenberg; James W Thomas; John Williams; Mark Boothby
Journal:  J Immunol       Date:  2013-08-16       Impact factor: 5.422

6.  Expression of IL-5 receptors on B cells: role in mucosal B cell responses.

Authors:  G R Harriman; K C Allison; W Strober
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

7.  Effects of transforming growth factor beta-1 and interleukin-5 on IgA isotype switching at the clonal level.

Authors:  M F Kagnoff; P H Kim
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

8.  Induction of immune responses in mice after oral immunization with recombinant Lactobacillus casei strains expressing enterotoxigenic Escherichia coli F41 fimbrial protein.

Authors:  Jian-Kui Liu; Xi-Lin Hou; Chun-Hua Wei; Li-Yun Yu; Xiao-Jie He; Gui-Hua Wang; Jong-Soo Lee; Chul-Joong Kim
Journal:  Appl Environ Microbiol       Date:  2009-05-15       Impact factor: 4.792

9.  Immunogenicity of a live recombinant Salmonella enterica serovar typhimurium vaccine expressing pspA in neonates and infant mice born from naive and immunized mothers.

Authors:  Huoying Shi; Shifeng Wang; Kenneth L Roland; Bronwyn M Gunn; Roy Curtiss
Journal:  Clin Vaccine Immunol       Date:  2010-01-06

10.  Localization of IFN-gamma and IL-6 mRNA in murine intestine by in situ hybridization.

Authors:  S Bao; S Goldstone; A J Husband
Journal:  Immunology       Date:  1993-12       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.